Viewing StudyNCT00002266



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002266
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDSARC Patients
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization: NIH AIDS Clinical Trials Information Service

Organization Data

Organization: NIH AIDS Clinical Trials Information Service
Class: INDUSTRY
Study ID: 045B
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators